Rare bleeding disorders

Haemophilia

Volumn 14, Issue SUPPL. 3, 2008, Pages 202-210

  Peyvandi, Flora ^a   Cattaneo, M ^a   Inbal, A ^b   De Moerloose, P ^c   Spreafico, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b TEL AVIV UNIVERSITY   (Israel)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ARACHIDONIC ACID; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 13B; CLOPIDOGREL; DESMOPRESSIN; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FIBRINOGEN RECEPTOR; FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HEMOSTATIC AGENT; NOSE SPRAY; ORAL CONTRACEPTIVE AGENT; PURINERGIC P2Y12 RECEPTOR; RECOMBINANT BLOOD CLOTTING FACTOR 13 A2; RECOMBINANT BLOOD CLOTTING FACTOR 13 A2B2; RECOMBINANT BLOOD CLOTTING FACTOR 7A; THROMBIN RECEPTOR; THROMBOCYTE RECEPTOR; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

AFIBRINOGENEMIA; AUTOSOMAL RECESSIVE DISORDER; AUTOSOMAL RECESSIVE INHERITANCE; BERNARD SOULIER DISEASE; BLEEDING DISORDER; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CLINICAL TRIAL; CONSANGUINEOUS MARRIAGE; CONTINUOUS INFUSION; CRYOPRECIPITATE; DRUG HALF LIFE; DYSFIBRINOGENEMIA; FIBRIN CLOT; FIBRINOGEN DEFECT; GENE MUTATION; GENETIC DISORDER; GENETIC HETEROGENEITY; GLANZMANN DISEASE; HEMOPHILIA A; HEMOSTASIS; HUMAN; HYPOFIBRINOGENEMIA; LABORATORY DIAGNOSIS; MENORRHAGIA; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTHROMBIN DEFICIENCY; RARE DISEASE; REVIEW; SCOTT SYNDROME; SPONTANEOUS ABORTION; THROMBOCYTE DISORDER; THROMBOCYTE TRANSFUSION; THROMBOEMBOLISM; TRANSFUSION RELATED ACUTE LUNG INJURY; VITAMIN K DEFICIENCY; WOUND HEALING IMPAIRMENT;

BLOOD COAGULATION DISORDERS, INHERITED; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD PLATELET DISORDERS; DATABASES, GENETIC; DRUG ADMINISTRATION SCHEDULE; GENOTYPE; GREAT BRITAIN; HEMORRHAGIC DISORDERS; HUMANS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PHENOTYPE; PRACTICE GUIDELINES AS TOPIC;

EID: 44249092303     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01751.x     Document Type: Review

References (59)

1. Tuddenham EGD, Cooper DN. The Molecular Genetics of Haemostasis and Its Inherited Disorders. Oxford, UK: Oxford Medical Publications, 1994 (Oxford Monography on Medical Genetics No. 25)
2. Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia 2002; 8: 308-21.
3. Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104: 1243-52.
4. Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost 2003; 1: 1628-36.
5. Nieuwenhuis HK, Sakariassen KS, Houdijk WP, Nievelstein PF, Sixma JJ. Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: A defect in platelet spreading. Blood 1986; 68: 692-5.
6. Kehrel B, Balleisen L, Kokott R et al. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 1988; 71: 1074-8.
7. Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 1989; 84: 1440-5.
8. Hirata T, Kakizuka A, Ushikubi F, Fuse I, Okuma M, Narumiya S. Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder. J Clin Invest 1994; 94: 1662-7.
9. Cattaneo M, Gachet C. ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 1999; 19: 2281-5.
10. Cattaneo M, Lecchi A, Randi AM, McGregor JL, Mannucci PM. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate. Blood 1992; 80: 2787-96.
11. Cattaneo M, Lecchi A, Lombardi R, Gachet C, Zighetti ML. Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: Further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors. Arterioscler Thromb Vasc Biol 2000; 20: E101-6.
12. Nurden P, Savi P, Heilmann E et al. An inherited bleeding disorder linked to a defective interaction between ADP and its receptor on platelets. Its influence on glycoprotein IIb-IIIa complex function. J Clin Invest 1995; 95: 1612-22.
13. Cattaneo M, Zighetti ML, Lombardi R et al. Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding. PNAS 2003; 100: 1978-83.
14. Cattaneo M. Congenital disorders of platelet secretion. In: Gresele P, Page C, Fuster V, Vermylen J, eds. Platelets in Thrombotic and Non-Thrombotic Disorders. Cambridge: Cambridge University Press, 2002: 655-73.
15. Rao AK. Congenital disorders of platelet secretion and signal transduction. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia, PA: J.B. Lippincot Williams and Wilkins, 2001: 893-904.
16. Weiss HJ. Scott syndrome: A disorder of platelet coagulant activity. Semin Hematol 1994; 31: 312-9.
17. Hayward CP, Rao AK, Cattaneo M. Congenital platelet disorders: Overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia 2006; 12: 128-36.
18. Cattaneo M. Qualitative platelet disorders. In: O'Shaughnessy D, Makris M, Lillicrap D, eds. Practical Hemostasis and Thrombosis. Oxford: Blackwell Publishing, 2005: 83-90.
19. Cattaneo M, Mannucci PM. Desmopressin. In: Michelson AD, ed. PLATELETS. San Diego, CA: Academic Press, 2002: 855-65
20. Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor XIII: Structure and function. Thromb Res 1999; 94: 271-305.
21. Greenberg CS, Sane DC, Lai T. Factor XIII and fibrin stabilization. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis, 5th edn. Philadelphia: Lippincott Williams and Wilkins, 2006: 153-81.
22. Ichinose A. Physiopathology and regulation of factor XIII. Thromb Haemost 2001; 86: 57-65.
23. Saito M, Asakura H, Yoshida T, Ito K, Okafuji K, Matsuda T. A familial factor XIII subunit B deficiency. Br J Haematol 1990; 74: 290-4.
24. Ivaskevicius V, Seitz R, Kohler HP et al. International registry on factor XIII deficiency: A basis formed mostly on European data. Thromb Haemost 2007; 97: 914-21.
25. Lauer P, Metzner HJ, Zettimeissl G et al. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: Hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost 2002; 88: 967-74.
26. Lak M, Peyvandi F, Ali Sharifian A, Karimi K, Mannucci PM. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 2003; 8: 1852-3.
27. Inbal A, Lubetsky A, Krapp T et al. Impaired wound healing in factor XIII deficient mice. Thromb Haemost 2005; 94: 432-7.
28. Muszbek L, Adany R, Mikkola H. Novel aspects of blood coagulation factor XIII. I. Structure, distribution, activation and function. Crit Rev Clin Lab Sci 1996; 33: 357-421.
29. Grothaus-Pinke B, Gunzelmann S, Fauser AA, Kiehl MG. Factor XIII replacement in stem cell transplant (SCT) recipients with severe graft-versus-host disease of the bowel: Report of an initial experience. Transplantation 2001; 72: 1456-8.
30. Dardik R, Krapp T, Rosenthal E, Loscalzo J, Inbal A. Effect of factor XIII (FXIII) on migration, proliferation and apoptosis of monocytes, smooth muscle cells and fibroblasts. Cell Physiol Biochem 2007; 19: 113-20.
31. Sarvary A, Szucs S, Balogh I et al. Possible role of factor XIII subunit A in Fc gamma and complement receptor-mediated phagocytosis. Cell Immunol 2004; 228: 81-90.
32. Dardik R, Solomon A, Loscalzo J et al. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler Thromb Vasc Biol 2003; 23: 1472-7.
33. Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A. Factor XIII A subunit deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood 2003; 102: 4410-12.
34. Inbal A, Muszbek L. Inherited coagulation factor deficiencies and pregnancy loss. Semin Thromb Hemost 2003; 29: 171-4.
35. Fickenscher K, Aab A, Stuber W. A Photometric assay for blood coagulation factor XIII. Thromb Haemost 1991; 65: 535-40.
36. Katona E, Haramura G, Karpati L, Fachet J, Muszbek L. A simple, quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2). Thromb Haemost 2000; 83: 268-73.
37. Gootenberg JE. Factor concentrates for the treatment of factor XIII deficiency. Curr Opin Hematol 1998; 5: 372-5.
38. Anwar R, Miloszewski KJA. Factor XIII deficiency. Review. Br J Haematol 1999; 107: 468-84.
39. Lovejoy AE, Reynolds TC, Visich JE et al. Safety and Pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood 2006; 108: 57-62.
40. Haverkate F, Samama M. Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost 1995; 73: 151-61.
41. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol 1999; 107: 204-6.
42. Acharya SS, Coughlin A, Dimichele DM, North American Rare Bleeding Disorder Study Group. Rare Bleeding Disorder Registry: Deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2004; 2: 248-56.
43. Bolton-Maggs PHB, Perry DJ, Chalmers EA et al. The rare coagulation disorders - review with guidelines for management from the United Haemophilia Centre Doctor's Organisation. Haemophilia 2004; 10: 593-628.
44. Peyvandi F, Haertel S, Knaub S, Mannucci PM. Incidence of bleeding symptoms in 100 patients with inherited afibrinogenemia or hypofibrinogenemia. J Thromb Haemost 2006; 4: 1634-7.
45. McDonagh J. Dysfibrinogenemia and other disorders of fibrinogen structure or function. In: Colman R, Hirsh J, Marder V, Clowes A, George J, eds. Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Chapter 53. Philadelphia: Lippincott Williams and Wilkins, 2001: 855-92
46. Maghzal GJ, Brennan SO, Homer VM, George PM. The molecular mechanisms of congenital hypofibrinogenaemia. Cell Mol Life Sci 2004; 61: 1427-38.
47. Neerman-Arbez M, de Moerloose P. Mutation in the fibrinogen gene cluster accounting for congenital afibrinogenemia: An update and report of 10 novel mutations. Hum Mutat 2007; 28: 540-53.
48. Hanss M, Biot F. A database for human fibrinogen variants. Ann N Y Acad Sci 2001; 936: H9-90. Available at: http://www.geht.org/databaseang/ fibrinogen (last accessed on 10 th December 2007).
49. Roberts HR, Stinchcombe TE, Gabriel DA. The dysfibrinogenaemias. Br J Haematol 2001; 114: 249-57.
50. Kreuz W, Meili E, Peter-Salonen K et al. Pharmacokinetic properties of a pasteurised fibrinogen concentrate. Transfus Apher Sci 2005; 32: 239-46.
51. Kobayashi T, Kanayama N, Tokunaga N, Asashina T, Terao T. Prenatal and peripartum management of congenital afibrinogenaemia. Br J Haematol 2000; 109: 364-6.
52. Hayes T. Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med 2002; 126: 1387-90.
53. Schuepbach RA, Meili EO, Schneider E, Peter U, Bachli EB. Lepirudin therapy for thrombotic complications in congenital afibrinogenaemia. Thromb Haemost 2004; 91: 1044-6.
54. Zhang B, Kaufman RJ, Ginsburg D. LMAN1 and MCFD2 form a cargo receptor complex and interact with coagulation factor VIII in the early secretory pathway. J Biol Chem 2005; 280: 25881-6.
55. Nichols WC, Seligsohn U, Zivelin A et al. Mutations in the ER-Golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 1998; 93: 61-70.
56. Zhang B, Cunningham MA, Nichols WC et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet 2003; 34: 220-5.
57. Brenner B. Hereditary deficiency of all vitamin K-dependent coagulation factors. Thromb Haemost 2000; 84: 935-6.
58. Rost S, Fregin A, Ivaskevicius V et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2. Nature 2004; 427: 537-41.
59. Peyvandi F, Kaufman RJ, Seligsohn U et al. Rare bleeding disorders. Haemophilia 2006; 12(Suppl. 3): 137-42.